| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/22/2007 | WO2006096489A3 Anti-m-csf antibody compositions having reduced levels of endotoxin |
| 03/22/2007 | WO2005092377A9 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 03/22/2007 | US20070067874 Plants which synthesize a modified starch, process for the production thereof and modified starch |
| 03/22/2007 | US20070067856 Therapeutic agent for NGF |
| 03/22/2007 | US20070067854 Chimeric mouse having an immune system constructed with human CD34+ cells and use thereof |
| 03/22/2007 | US20070066812 Fibroblast growth factor homologous factor-2 and methods of use |
| 03/22/2007 | US20070066811 Adipocyte complement related protein zacrp3x2 |
| 03/22/2007 | US20070066810 Homogeneous preparations of il-28 and il-29 |
| 03/22/2007 | US20070066809 Monoclonal antibodies to gastrin hormone |
| 03/22/2007 | US20070066806 Separation methods |
| 03/22/2007 | US20070066805 Human tumor necrosis factor receptor |
| 03/22/2007 | US20070066804 Polypeptide of given sequence; inducing HLA (human leukocyte antigen) restricted cytotoxic T lymphocytes |
| 03/22/2007 | US20070066803 Method to control tumor progression and invasiveness |
| 03/22/2007 | US20070066801 Identification of reagents for the diagnosis and study of francisella |
| 03/22/2007 | US20070066800 Apo2l(trail) receptor binding peptides and uses thereof |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070066535 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 03/22/2007 | US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/22/2007 | US20070065919 produces anti-Staphylococcus antibodies; monoclonal antibody is produced by providing a population of B-lymphocytes from a donor, immortalizing the population, separating a plurality of cells from the population to yield a first oligoclonal cell culture, culturing the the cell culture; |
| 03/22/2007 | US20070065912 Multiple Gene Expression including sORF Constructs and Methods with Polyproteins, Pro-Proteins, and Proteolysis |
| 03/22/2007 | US20070065909 Prokaryotically produced antibodies and uses thereof |
| 03/22/2007 | US20070065907 Process for the production of biological substances by perfusion culturing of suspended animal cells |
| 03/22/2007 | US20070065897 Human PRSS11-like S2 serine protease and uses thereof |
| 03/22/2007 | US20070065890 Method for promoting formation of facultative heterochromatin |
| 03/22/2007 | US20070065889 Compositions and methods to diagnose and treat lung cancer |
| 03/22/2007 | US20070065888 Reagents and methods for use in cancer diagnosis, classification and therapy |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/22/2007 | US20070065882 Acetylcholinesterase-derived peptides and uses thereof |
| 03/22/2007 | US20070065881 isolating heterocomplex GM2AP/GM2/MRP14 and mutated GM2AP/GM2/MRP14; gliotoxic |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065819 Novel fprl1 ligands and use thereof |
| 03/22/2007 | US20070065818 encoded by an isolated nucleic acid; a culture product; bioassay for determining the intracellular calcium concentration; immunoassay; bioluminescence resonance energy transfer (BRET) system |
| 03/22/2007 | US20070065518 Colostrum compositions and methods |
| 03/22/2007 | US20070065464 n immunogenic composition comprising a combination of Streptococcus pyogenes (GAS) antigens in pure form consisting of two to ten GAS antigens including a Spy0269 antigen comprising the amino acid sequence SEQ ID NO:1 and a Spy0416 antigen comprising the amino acid sequence SEQ ID; NO:122.; vaccines |
| 03/22/2007 | US20070065458 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs |
| 03/22/2007 | US20070065453 Transferrin-binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/22/2007 | US20070065451 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 03/22/2007 | US20070065447 Laminin-5 gamma2-binding peptides, related compositions, and use thereof |
| 03/22/2007 | US20070065446 Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer |
| 03/22/2007 | US20070065445 Novel cyclooxygenase variants and methods of use |
| 03/22/2007 | US20070065444 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 03/22/2007 | US20070065442 Compositions and methods for treating hyperimmune response in the eye |
| 03/22/2007 | US20070065441 Human PF4A receptors, nucleic acid encoding and antibodies binding thereto |
| 03/22/2007 | US20070065440 Antibody compositions and methods |
| 03/22/2007 | US20070065439 Antibodies against interleukin-1 beta |
| 03/22/2007 | US20070065438 Methods of inducing and maintaining immune tolerance |
| 03/22/2007 | US20070065435 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065434 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065433 Methods and compositions for the treatment of meconium aspiration syndrome |
| 03/22/2007 | US20070065431 A polynucleotide encoding a monomeric non-antibody ligand having a loop partly modified or replaced by or amino acid(s); improved solubility; medical diagnosis; targets of drugs, steroids, pesticides, antigens, growth factors, tumour markers, cell surface proteins or viral coat proteins |
| 03/22/2007 | US20070065430 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 03/22/2007 | US20070065429 Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques |
| 03/22/2007 | US20070065427 Agents that modulate immune cell activation and methods of use thereof |
| 03/22/2007 | US20070065426 Tumor necrosis factor binding ligands |
| 03/22/2007 | US20070065410 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/22/2007 | US20070065408 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b |
| 03/22/2007 | CA2820201A1 Identification of tumor-associated antigens for diagnosis and therapy |
| 03/22/2007 | CA2625815A1 Anti-cd3 antibody formulations |
| 03/22/2007 | CA2622603A1 Method for preparing immunoglobulin libraries |
| 03/22/2007 | CA2622575A1 Prok2 antagonists and methods of use |
| 03/22/2007 | CA2621363A1 Methods and compositions for modulating tumor cell activity |
| 03/22/2007 | CA2621248A1 Anti-human sr-b1 antibody reducing inflammation and treating auto-immunedisease |
| 03/22/2007 | CA2620712A1 Tumor associated antigen isc-468 for diagnosis and therapy |
| 03/22/2007 | CA2619298A1 Modified antigen binding molecules with altered cell signaling activity |
| 03/21/2007 | EP1764413A1 Protein preparation containing s1-5 |
| 03/21/2007 | EP1764371A1 Agonist antibodies that bind to the LT-beta receptor, thereby modulating adiposity-associated phenotypes, and their use in therapy |
| 03/21/2007 | EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/21/2007 | EP1764113A1 Antibodies against lung cancer, antigens and methods of use thereof for treating lung cancer |
| 03/21/2007 | EP1764109A1 Agonist antibodies that bind to the TWEAK receptor Fn14, thereby modulating adiposity-associated phenotypes, and their use in therapy |
| 03/21/2007 | EP1763582A2 Means and methods for controlling flowering in plants |
| 03/21/2007 | EP1763539A1 Treatment of bacterial infections |
| 03/21/2007 | EP1763366A1 Treatment of cancer |
| 03/21/2007 | EP1763365A2 Antibodies for selective apoptosis of cells |
| 03/21/2007 | EP1763364A2 Methods and compositions comprising supramolecular constructs |
| 03/21/2007 | EP1763361A2 Steroid sparing agents and their use |
| 03/21/2007 | EP1517703B1 Placental growth factor as a target for the treatment of osteoporosis |
| 03/21/2007 | EP1461359B1 Novel anti-igf-ir antibodies and uses thereof |
| 03/21/2007 | EP1337850B1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 03/21/2007 | EP1337629B1 Dipeptidyl peptidases |
| 03/21/2007 | EP1334195B1 Analogues, agonists, antagonists and variants of the oxidoreductase enzyme activity of the macrophage-migration inhibition factor (mif) as immunomodulators, medicaments, diagnostics and screening agents in inflammatory and immune diseases |
| 03/21/2007 | EP1313771B1 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 03/21/2007 | EP1115425B1 Autoantibody inhibitors |
| 03/21/2007 | EP1049717B1 Antibodies against human il-12 |
| 03/21/2007 | EP0966532B1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
| 03/21/2007 | EP0950107B1 Novel nucleic acid molecules from maize and their use for the production of modified starch |
| 03/21/2007 | EP0907724B1 Von willebrand factor multimerase |
| 03/21/2007 | EP0902839B1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 03/21/2007 | EP0805853B1 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 03/21/2007 | EP0574461B9 High affinity humanized monoclonal antibodies |
| 03/21/2007 | CN1934449A Improved method for diagnosing acute coronary syndrome |
| 03/21/2007 | CN1934266A Anti-myostatin antibodies |
| 03/21/2007 | CN1934247A Cancerous disease modifying antibodies |
| 03/21/2007 | CN1934246A Cancerous disease modifying antibodies |
| 03/21/2007 | CN1934134A Methods for inducing autolysis in infectious bacteria |
| 03/21/2007 | CN1934133A Anti-influenza type A virus monoclonal antibody and immunoassay instrument using the antibody |
| 03/21/2007 | CN1933853A Drug conjugates |
| 03/21/2007 | CN1933851A Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
| 03/21/2007 | CN1932517A Method for detecting or determining hcv core antigen and detecting or determining reagent used therefor |
| 03/21/2007 | CN1932016A Polynucleotide affecting SRE activity and its coding polypeptides and use |